0001773751-24-000152.txt : 20240522 0001773751-24-000152.hdr.sgml : 20240522 20240522161640 ACCESSION NUMBER: 0001773751-24-000152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240520 FILED AS OF DATE: 20240522 DATE AS OF CHANGE: 20240522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Okupe Oluyemi CENTRAL INDEX KEY: 0001907056 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 24973487 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST., #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 4 1 wk-form4_1716408990.xml FORM 4 X0508 4 2024-05-20 0 0001773751 Hims & Hers Health, Inc. HIMS 0001907056 Okupe Oluyemi 2269 CHESTNUT STREET, #523 SAN FRANCISCO CA 94123 0 1 0 0 Chief Financial Officer 1 Class A Common Stock 2024-05-20 4 S 0 6900 20.0063 D 161727 D Class A Common Stock 2024-05-21 4 M 0 28084 5.01 A 189811 D Class A Common Stock 2024-05-21 4 S 0 31433 17.8595 D 158378 D Class A Common Stock 2024-05-21 4 S 0 3349 17.9728 D 155029 D Class A Common Stock 2024-05-21 4 S 0 3349 17.9517 D 151680 D Stock Option (right to buy) 5.01 2024-05-21 4 M 0 28084 0 D 2032-02-23 Class A Common Stock 28084 936311 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.63 - $18.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.88 - $18.095. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.86 - $18.07. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. /s/ Alexandra Cotter Wilkins, Attorney-in-Fact 2024-05-22